ANNX
Annexon, Inc.
There isn't enough reported data to score ANNX yet.
ANNX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
ANNX's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
ANNX PE Valuation
ANNX has no meaningful PE right now: it lost money over the past year.
ANNX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect ANNX's revenue to grow, with its earnings and profitability holding steady.
ANNX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.02 | +$0.38 |
| Q2 2026 | -$1.14 | +$0.14 |
| Q1 2026 | -$1.20 | -$0.03 |
| Q4 2025 | -$1.34 | -$0.33 |
| Q3 2025 | -$1.40 | -$0.36 |
| Q2 2025 | -$1.28 | -$0.06 |
| Q1 2025 | -$1.17 | +$0.29 |
| Q4 2024 | -$1.01 | +$0.76 |
ANNX is still losing money, but far less than before: $1.02 per share over the past year, against $3.78 at its worst in mid-2022.
ANNX Quarterly Revenue
ANNX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$48.7M | +$3.7M |
| Q2 2026 | -$48.1M | -$10.1M |
| Q1 2026 | -$46.8M | +$3.3M |
| Q4 2025 | -$45.9M | -$9.9M |
| Q4 2024 | -$36M | -$12.5M |
| Q4 2023 | -$23.5M | +$3.9M |
| Q3 2023 | -$28.3M | +$2.6M |
| Q2 2023 | -$36.4M | -$7.4M |
ANNX has burned cash in almost every quarter: −$190M over the past year, against −$177M the year before.
ANNX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.8% | +3.6M shares |
| 1 year | +37% | +55.5M shares |
| 3 years | +172% | +129M shares |
| 5 years | +436% | +166M shares |
ANNX has 205M diluted shares, up 37% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2020 | — |
| Q4 2019 | — |
ANNX Net Leverage
ANNX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ANNX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.4 | Neutral |
| Stochastic | 31.1 | Neutral |
ANNX's weekly RSI is 43 (neutral) and its Stochastic is 31 (neutral).
ANNX PE vs Healthcare Sector
ANNX has no meaningful PE right now: it lost money over the past year.
ANNX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.90 | 1.8% above |
| 20 week MA | $4.62 | 14% below |
| 50 week MA | $5.10 | 22% below |
| 100 week MA | $3.99 | 0.5% below |
| 200 week MA | $4.35 | 8.7% below |
ANNX has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 8.7% below its 200-week average.
ANNX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.8 | $30.0 | +69% |
| 2021 | $30.0 | $12.8 | -57% |
| 2022 | $12.8 | $5.45 | -58% |
| 2023 | $5.45 | $4.54 | -17% |
| 2024 | $4.54 | $5.19 | +14% |
| 2025 | $5.19 | $5.11 | -1.5% |
| 2026 YTD | $5.11 | $3.97 | -22% |
ANNX has finished lower in four of the last six years. It's down 22% so far in 2026.